Our study demonstrates that CEA enhances the proliferation and migration of non-small cell lung cancer (NSCLC) while also inhibiting cisplatin-induced apoptosis in NSCLC cells. The gene discussed is CEACAM5; the disease is non-small cell lung carcinoma.